Lundbeck LLC
Quick facts
Marketed products
- Sabril® · Neurology
Sabril (vigabatrin) irreversibly inhibits GABA transaminase, the enzyme that breaks down the neurotransmitter GABA, thereby increasing GABA levels in the brain.
Phase 3 pipeline
- Clobazam High Dose · Neurology
Clobazam is a benzodiazepine that enhances inhibitory GABAergic neurotransmission in the central nervous system to reduce seizure activity. - Clobazam Low Dose · Neurology
Clobazam is a benzodiazepine that enhances inhibitory GABAergic neurotransmission in the central nervous system to reduce seizure activity. - Clobazam Medium Dose · Neurology
Clobazam is a benzodiazepine that enhances inhibitory GABAergic neurotransmission in the central nervous system to reduce seizure activity.
Phase 2 pipeline
Phase 1 pipeline
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Frequently asked questions about Lundbeck LLC
What are Lundbeck LLC's marketed drugs?
Top marketed products include Sabril®.
What is Lundbeck LLC's pipeline?
Lundbeck LLC has 3 drugs in Phase 3, 1 in Phase 2, 1 in Phase 1. Late-stage candidates include Clobazam High Dose, Clobazam Low Dose, Clobazam Medium Dose.
Related
- Sabril® · Neurology
- Sector hub: All tracked pharma companies